Holding(s) in Company

Oxford Biomedica PLC
28 June 2007


TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES


1. Identity of the issuer or the underlying issuer of existing shares to which
   voting rights are attached (ii):

   Oxford BioMedica plc

2. Reason for the notification (please state Yes/No): ( )

   An acquisition or disposal of voting rights: (Yes)
   An acquisition or disposal of financial instruments which may result in the
   acquisition of shares already issued to which voting rights are attached: ( )
   An event changing the breakdown of voting rights: ( )
   Other (please specify) : ( )

3. Full name of person(s) subject to the notification obligation (iii):

   Oxxon Therapeutics Holdings, Inc.

4. Full name of shareholder(s) (if different from 3.) (iv):

   n/a

5. Date of the transaction (and date on which the threshold is crossed or
   reached if different) (v):

   22 June 2007

6. Date on which issuer notified:

   27 June 2007

7. Threshold(s) that is/are crossed or reached:

   Falls below 4% threshold

8. Notified details:

 
A: Voting rights attached to shares

Class/type of shares Situation previous to the Triggering transaction
if possible using                          (vi)
the ISIN CODE
                      Number of shares  Number of voting Rights (viii)
GB0006648157                25,814,138                      25,814,138


Resulting situation after the triggering transaction (vii)
Class/type of shares  Number of shares    Number of voting       % of voting
if possible using                           rights (ix)            rights
the ISIN CODE
                                Direct Direct (x)    Indirect   Direct Indirect
                                                         (xi)
GB0006648157                         0          0           0       0%       0%


B: Financial Instruments

Resulting situation after the triggering transaction (xii)
Type of     Expiration Date  Exercise/Conversion Number of voting     % of voting
financial   (xiii)           Period/Date (xiv)   rights that may be   rights
instrument                                       acquired if the
                                                 instrument is
                                                 exercised/
                                                 converted.
N/A          N/A              N/A                N/A                  N/A


Total (A+B)
 Number of voting rights  % of voting rights
                       0                  0%


9. Chain of controlled undertakings through which the voting rights and/or the
   financial instruments are effectively held, if applicable (xv):
   N/A


Proxy Voting:

10. Name of the proxy holder:

    N/A

11. Number of voting rights proxy holder will cease to hold:

    N/A

12. Date on which proxy holder will cease to hold voting rights:

    N/A

13. Additional information:

    None

14. Contact name:

    Emma Johnson

15. Contact telephone number:

    07879 631 420





28 June 2007



                      This information is provided by RNS
            The company news service from the London Stock Exchange